메뉴 건너뛰기




Volumn 18, Issue 1, 2006, Pages 3-7

Consolidation therapy in ovarian cancer: Where do we stand?

Author keywords

Consolidation therapy; Maintenance therapy; Ovarian cancer

Indexed keywords

ALPHA INTERFERON; ALTRETAMINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; OREGOVOMAB; PACLITAXEL; PACLITAXEL POLIGLUMEX; TOPOTECAN;

EID: 33646489032     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000192995.20040.ff     Document Type: Review
Times cited : (9)

References (22)
  • 1
    • 2342466407 scopus 로고    scopus 로고
    • American Cancer Society Website. Cancer Statistics 2004. www.acs.org.
    • (2004) Cancer Statistics
  • 2
    • 0141688377 scopus 로고    scopus 로고
    • Phase III trial of carboplatin and paclitaxel compared to cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
    • Ozols RF, Bundy BN, Greer BE, et al. Phase III trial of carboplatin and paclitaxel compared to cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003; 21:3194-3200.
    • (2003) J Clin Oncol , vol.21 , pp. 3194-3200
    • Ozols, R.F.1    Bundy, B.N.2    Greer, B.E.3
  • 3
    • 0030054309 scopus 로고    scopus 로고
    • Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
    • McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996; 334:1-6.
    • (1996) N Engl J Med , vol.334 , pp. 1-6
    • McGuire, W.P.1    Hoskins, W.J.2    Brady, M.F.3
  • 4
    • 0038690538 scopus 로고    scopus 로고
    • Phase III randomized trial of 12 versus 3 months of maintenance paclitaxed in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A southwest oncology group and gynecologic oncology group trial
    • Markman M, Liu PY, Wilczynski S, et al. Phase III randomized trial of 12 versus 3 months of maintenance paclitaxed in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a southwest oncology group and gynecologic oncology group trial. J Clin Oncol 2003; 21:2460-2465.
    • (2003) J Clin Oncol , vol.21 , pp. 2460-2465
    • Markman, M.1    Liu, P.Y.2    Wilczynski, S.3
  • 5
    • 4644354408 scopus 로고    scopus 로고
    • Timing isn't everything: An analysis of when to start salvage chemotherapy in ovarian cancer
    • McMeekin DS, Tillmanns T, Chaudry T, et al. Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer. Gynecol Oncol 2004; 95:157-164. Retrospective trial analyzing the experience of patients with CCR who received salvage chemotherapy at recurrence. Inferences are made to GOG 178 with regards to timing of salvage therapy.
    • (2004) Gynecol Oncol , vol.95 , pp. 157-164
    • McMeekin, D.S.1    Tillmanns, T.2    Chaudry, T.3
  • 6
    • 0037862963 scopus 로고    scopus 로고
    • Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial
    • The ICON, Collaborators AGO. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet 2003; 361:2099-2105.
    • (2003) Lancet , vol.361 , pp. 2099-2105
  • 7
    • 0026720218 scopus 로고
    • Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma
    • Hakes TB, Chalas E, Hoskins WJ, et al. Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma. Gynecol Oncol 1992; 45:284-289.
    • (1992) Gynecol Oncol , vol.45 , pp. 284-289
    • Hakes, T.B.1    Chalas, E.2    Hoskins, W.J.3
  • 8
    • 0027276217 scopus 로고
    • A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: A Danish Ovarian Study Group Trial
    • Bertelsen K, Jakobsen A, Stroyer I, et al. A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: A Danish Ovarian Study Group Trial. Gynecol Oncol 1993; 49:30-36.
    • (1993) Gynecol Oncol , vol.49 , pp. 30-36
    • Bertelsen, K.1    Jakobsen, A.2    Stroyer, I.3
  • 9
    • 30444431612 scopus 로고    scopus 로고
    • A randomized study of epithelial ovarian cancer: Is chemotherapy useful after complete remission?
    • Nicoletto MO, Tumolo S, Falci C, et al. A randomized study of epithelial ovarian cancer: is chemotherapy useful after complete remission? Int J Med Sci 2004; 1:116-125. Randomized clinical trial comparing observation to maintenance chemotherapy with sequential 5-FU and cisplatin.
    • (2004) Int J Med Sci , vol.1 , pp. 116-125
    • Nicoletto, M.O.1    Tumolo, S.2    Falci, C.3
  • 10
    • 20444470006 scopus 로고    scopus 로고
    • Consolidation therapy with weekly paclitaxed infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: An extended follow-up
    • Skinner EN, Boruta DM, Gehrig PG, et al. Consolidation therapy with weekly paclitaxed infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: An extended follow-up. Gynecol Oncol 2005; 98:59-62.
    • (2005) Gynecol Oncol , vol.98 , pp. 59-62
    • Skinner, E.N.1    Boruta, D.M.2    Gehrig, P.G.3
  • 11
    • 1242320050 scopus 로고    scopus 로고
    • Consolidation therapies revisited: Weekly paclitaxel
    • Pecorelli S, Odicino F, Favalli G. Consolidation therapies revisited: weekly paclitaxel. Int J Gynecol Cancer 2003; 13 (Suppl 2):208-211.
    • (2003) Int J Gynecol Cancer , vol.13 , Issue.2 SUPPL. , pp. 208-211
    • Pecorelli, S.1    Odicino, F.2    Favalli, G.3
  • 12
    • 2042487233 scopus 로고    scopus 로고
    • Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the South west Oncology Group
    • Alberts DS, Jiang C, Liu PY, et al. Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the South west Oncology Group. Int J Gynecol Cancer 2004; 14:224-228.
    • (2004) Int J Gynecol Cancer , vol.14 , pp. 224-228
    • Alberts, D.S.1    Jiang, C.2    Liu, P.Y.3
  • 13
    • 4344678332 scopus 로고    scopus 로고
    • Topotecan compared with no therapy after response to surgery and carboplatin/Paclitaxel in patients with ovarian cancer: Multicenter Italian trials in ovarian cancer (MITO-1) randomized study
    • De Placido S, Scambia G, Di Vagno G, et al. Topotecan compared with no therapy after response to surgery and carboplatin/Paclitaxel in patients with ovarian cancer: multicenter Italian trials in ovarian cancer (MITO-1) randomized study. J Clin Oncol 2004; 22:2635-2642. Randomized clinical trial comparing observation to maintenance chemotherapy with topotecan.
    • (2004) J Clin Oncol , vol.22 , pp. 2635-2642
    • De Placido, S.1    Scambia, G.2    Di Vagno, G.3
  • 14
    • 4544355308 scopus 로고    scopus 로고
    • Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: A long-term survival analysis
    • Debby A, Levy T, Hayat H, et al. Whole-abdomen, single-dose consolidation radiotherapy in patients with pathologically confirmed complete remission of advanced ovarian epithelial carcinoma: a long-term survival analysis. Int J Gynecol Cancer 2004; 14:794-798. Interesting trial evaluating a single fraction of abdominal radiation therapy for consolidation.
    • (2004) Int J Gynecol Cancer , vol.14 , pp. 794-798
    • Debby, A.1    Levy, T.2    Hayat, H.3
  • 15
    • 0141683287 scopus 로고    scopus 로고
    • Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment
    • Sorbe B. Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer 2003; 13:278-286.
    • (2003) Int J Gynecol Cancer , vol.13 , pp. 278-286
    • Sorbe, B.1
  • 16
    • 0041384504 scopus 로고    scopus 로고
    • 32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: A randomized trial of the gynecologic oncology group
    • 32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the gynecologic oncology group. J Clin Oncol 2003; 21:2849-2855.
    • (2003) J Clin Oncol , vol.21 , pp. 2849-2855
    • Varia, M.A.1    Stehman, F.B.2    Bundy, B.N.3
  • 17
    • 4444383336 scopus 로고    scopus 로고
    • Randomized, placebo-controlled study of Oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer
    • Berek JS, Taylor PT, Gordon A, et al. Randomized, placebo-controlled study of Oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer. J Clin Oncol 2004; 22:3507-3516. A subgroup of CCR patients who might benefit from immunotherapy is identified.
    • (2004) J Clin Oncol , vol.22 , pp. 3507-3516
    • Berek, J.S.1    Taylor, P.T.2    Gordon, A.3
  • 18
    • 4344703324 scopus 로고    scopus 로고
    • Maintenance treatment with interferon for advanced ovarian cancer: Results of the Northern and Yorkshire gynaecology group randomized phase III study
    • Hall GD, Brown JM, Coleman RE, et al. Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomized phase III study. Br J Cancer 2004; 91:621-626. Randomized trial showing no benefit to interferon over observation in consolidation.
    • (2004) Br J Cancer , vol.91 , pp. 621-626
    • Hall, G.D.1    Brown, J.M.2    Coleman, R.E.3
  • 19
    • 0742272538 scopus 로고    scopus 로고
    • Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer consolidative intraperitoneal cisplatin in ovarian cancer
    • Topuz E, Eralp Y, Saglam S, et al. Efficacy of intraperitoneal cisplatin as consolidation therapy in patients with pathologic complete remission following front-line therapy for epithelial ovarian cancer consolidative intraperitoneal cisplatin in ovarian cancer. Gynecol Oncol 2004; 92:147-151.
    • (2004) Gynecol Oncol , vol.92 , pp. 147-151
    • Topuz, E.1    Eralp, Y.2    Saglam, S.3
  • 20
    • 2442501421 scopus 로고    scopus 로고
    • Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: Results of a phase I/II trial
    • Sabbatini P, Aghajanian C, Leitao M, et al. Intraperitoneal cisplatin with intraperitoneal gemcitabine in patients with epithelial ovarian cancer: results of a phase I/II trial. Clin Cancer Res 2004; 10:2962-2967.
    • (2004) Clin Cancer Res , vol.10 , pp. 2962-2967
    • Sabbatini, P.1    Aghajanian, C.2    Leitao, M.3
  • 21
    • 15444375965 scopus 로고    scopus 로고
    • Intraperitoneal hyperthermic chemotherapy in ovarian cancer
    • Gori J, Castano R, Toziano M, et al. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer 2005; 15:233-239.
    • (2005) Int J Gynecol Cancer , vol.15 , pp. 233-239
    • Gori, J.1    Castano, R.2    Toziano, M.3
  • 22
    • 10044280462 scopus 로고    scopus 로고
    • Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer
    • Micha JP, Goldstein BH, Maittison JA, et al. Experience with single-agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer. Gynecol Oncol 2005; 96:132-135.
    • (2005) Gynecol Oncol , vol.96 , pp. 132-135
    • Micha, J.P.1    Goldstein, B.H.2    Maittison, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.